透析和认知障碍 透析和认知障碍
Chris W McIntyre1,2, Arsh Jain3
1Lilibeth Caberto Kidney Clinical Research Unit, Lawson Health Research Institute, London, Ontario, Canada. cmcint48@uwo.ca.
Nature reviews. Nephrology
|April 24, 2025
概括
维持透析加速慢性病患者的认知衰退. 这种经常被忽视的效应影响患者,护理人员和医疗保健系统,需要对其机制和干预措施进行进一步的研究.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 神经学 神经学
- 认知科学 认知科学
背景情况:
- 慢性病 (CKD) 接受维持透析的患者表现出比未接受透析的晚期病患者更快的认知衰退.
- 这种认知障碍对患者,护理人员和医疗保健系统来说很重要,但往往被低估.
- 慢性病患者的并发症可能会影响大脑健康,但透析本身越来越多地与认知能力下降有关.
研究的目的:
- 探索透析诱导慢性病患者认知衰退背后的机制.
- 审查已确定的和潜在的病理生理路径,将透析与大脑变化联系起来.
- 考虑治疗干预措施,以减轻这一群体的认知障碍.
主要方法:
- 审查关于透析和认知功能在CKD现有的文献.
- 分析证据表明透析治疗导致大脑结构和功能变化.
- 探索潜在的治疗策略,单一和复杂的.
主要成果:
- 血液透析和腹腔透析都与结构和功能性大脑变化有关.
- 透析可以导致短期的神经症状,如混乱和脑雾.
- 长期影响包括认知功能能力的逐渐减少.
结论:
- 透析疗法在慢性病患者渐进性认知障碍的病理生理学中发挥着核心作用.
- 了解这些机制对于开发有效的干预措施至关重要.
- 需要进一步的研究和治疗方法来解决透析相关的认知衰退.
相关概念视频
Dialysis
228
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
228
Cognitive Development During Adulthood
23
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
23
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
85
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
85
Factors Affecting Renal Clearance: Renal Impairment
30
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
30
Dementia
65
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
65
Alzheimer's Disease: Overview
317
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
317


